about
A landscape of driver mutations in melanomaMutational heterogeneity in cancer and the search for new cancer-associated genesIntegrative analysis of the melanoma transcriptomeMelanoma genome sequencing reveals frequent PREX2 mutationsExome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerThe genomic complexity of primary human prostate cancerMutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromesInitial genome sequencing and analysis of multiple myelomaSomatic mutations affect key pathways in lung adenocarcinomaWhole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.The genomic landscape of pediatric Ewing sarcoma.The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataMapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencingExome sequencing, ANGPTL3 mutations, and familial combined hypolipidemiaGenetic mapping and exome sequencing identify variants associated with five novel diseasesMedulloblastoma exome sequencing uncovers subtype-specific somatic mutationsA scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries.Targeted exon sequencing by in-solution hybrid selection.Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.Systematic genomic and translational efficiency studies of uveal melanoma.Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.ContEst: estimating cross-contamination of human samples in next-generation sequencing data.Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.Sequence analysis of mutations and translocations across breast cancer subtypesSF3B1 and other novel cancer genes in chronic lymphocytic leukemiaLandscape of genomic alterations in cervical carcinomas.Absolute quantification of somatic DNA alterations in human cancerA homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder.Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.RNF43 is frequently mutated in colorectal and endometrial cancersSporadic hemangioblastomas are characterized by cryptic VHL inactivation.Temporal dissection of tumorigenesis in primary cancersThe functional spectrum of low-frequency coding variationA remarkably simple genome underlies highly malignant pediatric rhabdoid cancersPrognostically relevant gene signatures of high-grade serous ovarian carcinoma.Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
P50
Q24603357-79E85633-5B32-45C2-86B8-5197A52179C1Q24606956-8E496310-B151-4742-B3F3-BBBE9079C43AQ24608060-2BD603F1-3CE8-44B9-B973-89A2371080D3Q24610463-9BA8A8FE-9DB6-4B57-AD89-4303FAD5A7F4Q24616117-3BE8C429-38DF-47AD-9AF2-D45520A81272Q24617949-E60A23FB-DA0C-4B4E-9210-53C59A6C4739Q24625476-FD929B37-407A-44D7-B613-3CE27B90F569Q24629117-5610ECDF-3FEB-4AA6-8641-D1612757A56BQ24648102-A3D1E024-D11A-4BA2-8922-7180F1E116F5Q27853005-240DFED9-B53F-43AF-B94B-689099C7818AQ27853014-B28A5E7B-5FCC-47AA-B3D7-446A759C8D52Q27853063-C68C35C7-1AF3-4A4E-820D-37FE482EBF6EQ27860742-F714B6ED-B647-477A-BBC6-3A943F9B8C76Q28275103-42B0C59D-0FA1-4962-82C6-3E24FD35D4CFQ28285241-3DAD1D99-DDBA-4CD4-8324-DDC05835B822Q28295479-61567C51-8B22-4282-A088-68EB18584D61Q28478905-DB403C5C-B7C3-479D-AE34-5E6148527525Q30040534-7E9875B7-5F74-4999-A78C-FA297224268AQ30475515-A1075EAC-9928-4A73-B26B-4B7D93CD2FA9Q33617969-81D7BEB0-9E8C-4DFB-BA64-57C23D99CB3FQ33667666-3E894D71-B111-4194-BF31-CDABA5E0697FQ33693912-8C441410-B124-443F-80B3-B2994C190E20Q33774682-093E2980-8064-4E7B-81CA-49CBCFF25514Q33778295-E4D68800-2938-4A6A-9A92-F2FFB7897EE7Q33917224-B49D4C83-CC19-4D3B-BE61-381CD87E5DCBQ33976298-9F6A4500-E290-49D3-8238-966FA89746B3Q34026081-D8DE1612-A3CC-4544-A7B1-72FB66773907Q34032470-D6EB1F5C-8EC4-4A13-B457-537387927885Q34093678-E7A37B5A-76AF-4170-B4E7-718F769BC350Q34169464-C2BA42CE-31EB-4EFD-8DC4-210273812DE7Q34271693-747330B3-80A9-4F3D-A91E-F4B5E81D717CQ34306101-40648BDC-55EB-4DAD-B093-9D1259373402Q34327021-F7F2FA3D-C741-4CE8-9643-6FEFC5DE8B17Q34817306-0B11DAA9-03EA-4CE4-901F-4F21B1BA431FQ34979062-32CDB2AA-08BC-4398-A44C-EA1821751C84Q35275682-E1E1C6D9-F756-492C-9FFE-17E315994B6DQ35840674-82DCE879-83A7-401E-A79B-D293B4EF9E31Q36129157-C19FE340-920F-4C9D-BB7C-A9A2187D7238Q36497294-D90AB3B6-1CF3-425D-9311-2E7875FE41E4Q36563549-705D0AF9-35AF-4C7F-8E83-3F2D77DA093B
P50
description
onderzoeker
@nl
name
Kristian Cibulskis
@en
Kristian Cibulskis
@es
Kristian Cibulskis
@sl
type
label
Kristian Cibulskis
@en
Kristian Cibulskis
@es
Kristian Cibulskis
@sl
prefLabel
Kristian Cibulskis
@en
Kristian Cibulskis
@es
Kristian Cibulskis
@sl
P106
P2038
Kristian_Cibulskis